Corticosteroid foam moves beyond scalp psoriasis

Article

Maui, Hawaii - Already FDA-approved for scalp psoriasis, clobetasol propionate foam is effective against mild to moderate psoriasis in other parts of the body as well.

Related Videos
Related Content

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.